Merck, Daiichi Sankyo Withdraw Application for Accelerated Approval of Lung Cancer Treatment

By Elias SchisgallMerck & Co. and Daiichi Sankyo have withdrawn their application seeking accelerated approval for a small cell lung cancer treatment, saying the data they had submitted to the Food and Drug Administration was insufficient.The two companies said they decided to withdraw the Biologic…